<p><div class="content-image-full"><img alt="" height="335" src="http://cdn.static-economist.com/sites/default/files/imagecache/full-width/images/2016/05/blogs/democracy-america/20160521_usp502_0.jpg" title="" width="595" /></div></p><p>“FIRST, do no harm.” Executives of pharmaceutical companies are not subject to this guiding principle of the Hippocratic oath—only doctors are. But increasingly, drug manufacturers are taking steps to ensure that their formulations do not wind up in syringes used for lethal injections of condemned prisoners. Last week, Pfizer, one of America’s largest drug companies, <a href="http://www.pfizer.com/files/b2b/GlobalPolicyPaperLethalInjection.pdf">announced</a> that it would no longer supply prisons with seven drugs used to impose the death penalty. “Pfizer’s mission is to apply science and our global resources to improve health and well-being at every stage of life”, the statement says. “Consistent with these values, Pfizer strongly objects to the use of its products as lethal injections for capital punishment.” The firm will sell the drugs “only for medically prescribed patient care and not for any penal purposes”, and take pains to ensure that the “select group of wholesalers, distributors and direct purchasers” who buy these drugs—pancuronium bromide, potassium chloride, propofol, midazolam, hydromorphone,...<a href="http://www.economist.com/blogs/democracyinamerica/2016/05/drug-drought">Continue reading</a>